Ifm Investors Pty LTD Ionis Pharmaceuticals Inc Transaction History

Ifm Investors Pty LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$34.54 - $47.25 $546,768 - $747,967	-15,830 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$42.51 - $63.78 $135,224 - $202,884	3,181 Added 25.15%	15,830 $712,000
Q4 2020 Jan 13, 2021	SELL	$45.3 - $60.27 $5,345 - $7,111	-118 Reduced 0.92%	12,649 $715,000
Q3 2020 Oct 16, 2020	BUY	$47.45 - $62.95 $148,850 - $197,474	3,137 Added 32.58%	12,767 $606,000
Q2 2020 Jul 13, 2020	SELL	$46.85 - $61.05 $96,604 - $125,885	-2,062 Reduced 17.64%	9,630 $568,000
Q1 2020 Apr 09, 2020	SELL	$41.6 - $63.4 $13,852 - $21,112	-333 Reduced 2.77%	11,692 $564,000
Q4 2019 Jan 13, 2020	SELL	$53.85 - $65.27 $11,254 - $13,641	-209 Reduced 1.71%	12,025 $726,000
Q3 2019 Nov 01, 2019	BUY	$59.06 - $72.15 $227,617 - $278,066	3,854 Added 45.99%	12,234 $733,000
Q2 2019 Jul 16, 2019	BUY	$62.09 - $86.14 $520,314 - $721,853	8,380 New	8,380 $539,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ifm Investors Pty LTD with notifications on news.